Common Research Facilities
  • Laboratory of Embryonic and Genetic Engineering
  • Laboratory of Technology
Contact

Medical Institute of Bioregulation Kyushu University
3-1-1 Maidashi, Higashi-ku, Fukuoka 812-8582, JAPAN
TEL+81-92-642-6814
FAX+81-92-642-6246

Mission of the Institute

Director Yusaku Nakabeppu

2018.4.1


 The Medical Institute of Bioregulation, Kyushu University, aims to enhance understanding of the Host-Defense System, an essential regulatory mechanism involved in human biology, at the cellular and molecular levels. With a long-term goal of curing diseases, the Institute has become one of the most active and productive research institutes in Japan, and has established itself as a world-renowned research institute for basic medical science. Our current goal is to establish a center of excellence for the Host-Defense System, focused on multi-scale and transomics medicine.

 The Medical Institute of Bioregulation was founded in April 1982, through combination of the Research Institute of Balneotherapeutics in Beppu and the Cancer Research Center in Fukuoka. In April 2001, to better serve the above aims in this rapidly changing era, the institute was largely reorganized into three departments (the Department of Molecular Genetics, the Department of Molecular and Cellular Biology, and the Department of Immunobiology and Neuroscience) with 12 divisions and two research centers (the Research Center for Genetic Information and the Research Center for Prevention of Infectious Diseases) with eight divisions. In April 2009 and April 2010, respectively, two new research centers, the Research Center for Infectious Diseases (three divisions) and the Multi-scale Research Center for Medical Science (five divisions) were established. In April 2010, our Institute was authorized as a Joint Usage/Research Center for the Multi-stratified Host Defense System by the Ministry of Education, Culture, Sports, Science and Technology, Japan; this promoted domestic and international joint research studies of the host-defense system. In April 2011, the existing clinical divisions and hospital in Beppu joined the Kyushu University Hospital, thus enabling our institute to concentrate on further advancements in basic medical research.

 In April 2013, the Research Center for Genetic Information was reorganized as the Research Center for Transomics Medicine, to establish an international center of excellence for basic medical research that focuses on multi-scale transomics approaches. Since April 2016, following our second approval as a Joint Usage/Research Center for the Multi-stratified Host Defense System, we have organized the Inter-University Research Network for Trans-Omics Medicine, which involves four Joint Usage/Research Centers in Japan. Our state-of-the-art facilities provide researchers worldwide with various services, including high-throughput DNA sequencing, microarray data collection, electron microscopic analysis, NMR analysis, proteomic analysis, transgenic animal production, and more.

 In April 2018, the Research Center for Infectious Diseases and the Multi-scale Research Center for Medical Science have been combined to establish the Research Center for Systems Immunology; the three departments within these centers have also been reorganized as the Department of Molecular and Structural Biology, the Department of Molecular and Cellular Biology, and the Department of Immunobiology and Neuroscience. Each department have three divisions, thus facilitating advanced studies of the Host-Defense System via Transomics Medicine. The Laboratory for Embryonic and Genetic Engineering and Laboratory for Technical Support have been reorganized as Research Promotion Unit. Our faculty members will continue to contribute to the education of the Graduate School of Medical Sciences and the Graduate School of Systems Life Sciences of Kyushu University.

 We sincerely hope that our research activity will enhance the understanding of complex pathological processes and speed the development of therapies to cure intractable diseases. We greatly appreciate your support and cooperation as we move forward.